FORM OF INDEMNIFICATION AGREEMENTIndemnification Agreement • May 19th, 2020 • Assertio Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 19th, 2020 Company Industry JurisdictionThis Indemnification Agreement (this “Agreement”) is entered into as of ________, 20__ (the “Effective Date”) by and between Assertio Holdings, Inc., a Delaware corporation (the “Company”), and ______________________ (the “Indemnitee”).
ASSERTIO HOLDINGS, INC. AMENDED AND RESTATED MANAGEMENT CONTINUITY AGREEMENTManagement Continuity Agreement • May 19th, 2020 • Assertio Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 19th, 2020 Company Industry JurisdictionThis Amended and Restated Management Continuity Agreement (the “Agreement”) is effective as of_______________, 20__ (the “Effective Date”) by and between ________________(“Employee”) and Assertio Holdings, Inc., a Delaware corporation (the “Company”). This Agreement is intended to provide Employee with certain benefits described herein upon the occurrence of specific events. This Agreement amends and restates that certain Management Continuity Agreement entered into between the parties as of ____________, 20___ (referred to herein as the “Prior Agreement”).
TRANSITION AGREEMENTTransition Agreement • May 19th, 2020 • Assertio Holdings, Inc. • Pharmaceutical preparations • California
Contract Type FiledMay 19th, 2020 Company Industry JurisdictionThis Transition Agreement (this “Agreement”) is entered into by and between Arthur Higgins (“Executive”) and Assertio Therapeutics, Inc., a Delaware corporation (“Assertio”) and is dated as of March 16 , 2020. The Executive and the Company shall collectively be referred to herein as the “Parties.”
AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • May 19th, 2020 • Assertio Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 19th, 2020 Company Industry JurisdictionThis Agreement and Plan of Merger (this “Agreement”), dated as of May 19, 2020, by and among Assertio Therapeutics, Inc., a Delaware corporation (“Assertio”), Assertio Holdings, Inc., a Delaware corporation (“Parent”) and a wholly owned subsidiary of Assertio, and Alligator Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”).